Biocompatible Membrane Composite for Immune Isolation and Vascularization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable devices face challenges in maintaining the viability of encapsulated bioactive entities due to the formation of foreign body giant cells, which hinder the formation of blood vessels near the cell impermeable interface, restricting access to oxygen and nutrients.
Innovation Solution
A biocompatible membrane composite with a first layer having a maximum pore size less than 1 micron and a second layer with bonded solid features spaced less than 50 microns, intimately bonded to the first layer, providing immune isolation while promoting vascularization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a cell impermeable membrane is used to encapsulate cells, then immune isolation is provided, but foreign body giant cells form and prevent blood vessel formation near the interface
Solution Approach 1:
The membrane is divided into two distinct layers: a first layer providing immune isolation with small pores, and a second layer promoting vascularization with larger pores and solid features. This segmentation allows each layer to perform its specific function without interfering with the other, resolving the contradiction between immune isolation and vascularization.
Solution Approach 2:
Different regions of the membrane have different properties: the first layer has small pores for immune isolation, while the second layer has larger pores and bonded solid features spaced less than 50 microns to promote blood vessel formation. This local differentiation allows the membrane to simultaneously provide immune isolation and facilitate vascularization at different locations.
2Reliability
If blood vessels are prevented from forming near the cell impermeable interface, then immune isolation is maintained, but access to oxygen and nutrients is restricted
Solution Approach 1:
The membrane is divided into two distinct layers: a first layer providing immune isolation with small pores, and a second layer promoting vascularization with larger pores and solid features. This segmentation allows each layer to perform its specific function without interfering with the other, resolving the contradiction between immune isolation and vascularization.
Solution Approach 2:
The second layer acts as an intermediary between the immune-isolating first layer and the host tissue, facilitating blood vessel formation and nutrient transport while the first layer maintains immune isolation. This intermediary layer resolves the contradiction by mediating between isolation and nourishment requirements.
3Object-affected harmful factors
If a porous structure is used to promote vascularization, then blood vessel formation is enhanced, but immune isolation capability is reduced
Solution Approach 1:
The membrane is divided into two distinct layers: a first layer providing immune isolation with small pores, and a second layer promoting vascularization with larger pores and solid features. This segmentation allows each layer to perform its specific function without interfering with the other, resolving the contradiction between immune isolation and vascularization.
Solution Approach 2:
Different regions of the membrane have different properties: the first layer has small pores for immune isolation, while the second layer has larger pores and bonded solid features spaced less than 50 microns to promote blood vessel formation. This local differentiation allows the membrane to simultaneously provide immune isolation and facilitate vascularization at different locations.
4Quantity of substance
If the membrane is made thinner to reduce diffusion distance, then nutrient access is improved, but mechanical strength is reduced
Solution Approach 1:
The membrane uses a composite structure with two layers made of different materials with distinct properties. The first layer provides immune isolation, while the second layer promotes vascularization and provides mechanical support through bonded solid features. This composite structure allows optimization of both diffusion efficiency and mechanical strength.
Solution Approach 2:
The membrane is divided into two distinct layers: a first layer providing immune isolation with small pores, and a second layer promoting vascularization with larger pores and solid features. This segmentation allows each layer to perform its specific function without interfering with the other, resolving the contradiction between immune isolation and vascularization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The membrane composite effectively mitigates the foreign body response, allowing sufficient blood vessel formation near the encapsulated cells, ensuring access to oxygen and nutrients, thereby maintaining cell viability and functionality.
Implementation Method 1
the first layer has an MPS (maximum pore size) less than about 1 micron... permit the passage of nutrients through but prevent the passage of the cells encapsulated therethrough
Implementation Method 2
a second layer having a majority of bonded solid features having a solid feature spacing less than about 50 microns... providing immune isolation while promoting vascularization
Data Source
AI summary
A biocompatible membrane composite including a cell impermeable layer and a mitigation layer is provided. The cell impermeable layer is impervious to vascular ingrowth and prevents cellular contact from the host. Additionally, the mitigation layer includes solid features. In at least one embodiment, mitigation layer has therein bonded solid features. In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded or otherwise connected to each other to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned external to or within the biocompatible membrane composite to provide support to and prevent distortion. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.


